Many diseases share the same symptoms, causing people to get confused and either undermine or overwhelm themselves with worries. With the current flu season on the rise, people in the United States are being very careful about their health and are taking necessary precautions to make sure they do not catch any more respiratory illnesses. Often these diseases show symptoms like coughing and wheezing, nothing that warrants anything more than a general doctor’s visit, sometimes people even think it it is a simple cold, but it could be something worse!
The Centers For Disease Control and Prevention (CDC) report on 28 February, last Friday on Respiratory Virus Activity Levels reported a moderate number of people are seeking medical help for respiratory illnesses. The flu is sending many people to the emergency room, RSV Respiratory syncytial virus has been sending many people to the ER along with COVID-19.
While flu test results are slightly less positive than last week, COVID-19 and RSV test results are about the same. In our community's wastewater, the flu virus is still very high, COVID-19 is moderate, and RSV is low. Looking forward, we expect COVID-19 emergency room visits to stay low. While flu visits are still high, they should start to go down soon.
So, even though it might feel like winter is ending, these viruses are still active, and we need to be careful. They are not going away quickly and can still spread easily. Here are some symptoms that should be treated with urgency right now.
When you're really sick, you might not feel like eating or drinking. This can lead to dehydration, which is when your body doesn't have enough water. If your pee is dark yellow, or you feel dizzy, you might be dehydrated. If you pass out, get confused, or your heart beats really fast, you need to go to the hospital right away. Healthcare professionals can give you fluids through a needle to help you feel better. Being dehydrated is very dangerous, and it is important to take it seriously.
If you're having trouble breathing, or if you're breathing really fast, that's a big sign. It could mean that you have pneumonia or that your body isn't getting enough oxygen. Shortness of breath is always a reason to go to the emergency room. Your body is telling you that something is seriously wrong. It is very important to seek help right away. Do not wait it out at home.
If your lips or fingers start to turn blue, that means you're not getting enough oxygen. Also, if you're so tired that you can barely get out of bed, that's another sign that you need to go to the hospital. These are serious symptoms that mean your body needs help right away.
Some people are more likely to get very sick from these viruses. Pregnant people, little kids, and older adults are at higher risk. Also, people who have health problems like heart or lung disease, or people with weak immune systems, are more likely to have serious problems. Older adults are often hospitalized with the flu, COVID, and RSV. These groups need to be extra careful to avoid getting sick. It is very important that these groups get vaccinated.
RSV is especially dangerous for babies and young children. It's one of the main reasons why young kids end up in the hospital. This virus can make it very hard for them to breathe. It is very important to protect young children from this virus, especially in the first few years of their lives.
Credit: iStock
Persistent hip pain is often dismissed as a muscle strain, poor posture, or fatigue. However, doctors warn that ongoing pain in the hip could sometimes be a signal for avascular necrosis (AVN) or osteonecrosis. This is a condition where reduced blood supply causes bone tissue to die. It may eventually lead to the collapse of the hip joint and serious mobility issues.
Avascular necrosis occurs when blood flow to a bone is interrupted or significantly reduced. The condition most commonly affects the hip joint, especially the femoral head (the rounded top portion of the thigh bone that fits into the hip socket). Over time, a lack of blood supply weakens the bone and may cause damage to the joint.
One of the biggest challenges with it is that symptoms appear gradually. In the early stages, people may only notice mild discomfort in the groin or hip area. As the disease progresses, pain may become more persistent. It can even worsen walking, climbing stairs, or standing for long periods. Some patients might eventually experience pain even while resting.
Several factors can increase the likelihood of developing AVN. Long-term steroid use, excessive alcohol, hip injuries, fractures, and certain medical conditions such as lupus and sickle cell disease are known risk factors.
If AVN continues to progress, the weakened bone may eventually collapse. This can lead to severe arthritis and chronic pain. In advanced stages, patients may struggle with everyday activities such as walking, bending, or even standing for extended periods. Doctors say delayed diagnosis is one of the biggest reasons many patients require joint replacement surgery later.
Early diagnosis is crucial because treatment works best before the bone collapses. MRI scans and imaging tests can help detect the condition in its early stages. Treatment may include medications, physical therapy, or surgery in advanced cases. Early medical attention may help preserve the joint and prevent permanent damage.
Credit: AI generated image
Higher temperatures in the US could increase heat-related heart disease by 200 per cent by 2050, according to an alarming study.
The research, published in JAMA Cardiology, predicts rising temperatures driven by climate change will dramatically increase heat-related heart disease in the US.
It is already known that extreme heat is detrimental to heart health and can potentially trigger heart attacks and other cardiovascular events.
"But this study is the first to map out exactly how bad the problem could get—county by county, across the US. It also highlighted how states with lower median household incomes are likely to face higher heat-related heart disease burden," said Gokul Parameswaran, research associate at the Case Western Reserve School of Medicine's Cardiovascular Research Institute and the study's lead author.
Researchers analyzed heart disease data in each county in the contiguous US from 2010 to 2016 to develop projections through 2050.
They found that the Pacific Northwest has the highest heat-related heart disease rate in the country. Southern states, however, are projected to see the steepest increases by 2050.
"Climate change is not just an environmental issue—it is a health equity crisis, and prioritizing vulnerable communities must be at the center of any heat mitigation strategy," said Salil Deo, associate professor in the Department of Surgery.
Also read: Global Temperatures Likely To Stay Near Record Levels For Next Five Years: WMO
The study also found that aging — independent of temperature increases — will contribute an additional 34 per cent increase in heat-related heart disease by 2050, simply because there will be more older adults by then.
The study comes amidst more frequent heat events in the US, which is also lasting longer, and the temperatures during heat events are going up.
The past 10 years, from 2015 to 2024, were the hottest on record globally. But in cities across the United States, the average rate of extreme heat events increased from two per year in the 1960s to 10 per year between 2010 and 2020, according to Center for Climate and Energy Solutions (C2ES), a Washington-based NGO.
Also Read:‘Heat Dome’ Triggering Record-Breaking May Temperatures In France, UK, Spain
Additionally, as of 2024, the average length of heat-wave season in the US has increased by 46 days since the 1960s.
According to the Centers for Disease Control and Prevention, when temperatures rise, the heart must work harder to keep the body cool, and the likelihood of developing sudden clots in the bloodstream increases.
Read More: Can Extreme Heat Trigger Heart Palpitations? Expert Explains Risks
This extra stress on the heart due to high heat may lead to heart attacks or sudden worsening of heart disease, especially in the elderly or those with prior heart conditions.
"Climate change is not a distant, abstract threat," said Sanjay Rajagopalan, director of the Cardiovascular Research Institute and chief of Cardiovascular Medicine at University Hospitals Harrington Heart & Vascular Institute.
"It is a present and growing danger to the hearts of every American, and it is coming for the most vulnerable among us first. The choices made today about greenhouse gas emissions, urban planning, and health care policy will determine whether tens of thousands of Americans live or die from heat-related heart disease by 2050," he added.
Credit: iStock
Diabetes is not only a disorder affecting blood sugar levels, but it also increases the risk of heart disease. People who have diabetes are more prone to get affected by heart attack, stroke, high blood pressure, and blockage of arteries than people without diabetes. Because of this strong link, diabetes care needs a focus on both blood sugar control and heart care.
One of the biggest improvements in diabetes care is the use of GLP-1 receptor agonist therapies. These medications not only help to control sugars but also reduce the risk of heart disease. When a person combines GLP-1 treatment along with a healthy lifestyle, they can improve their overall well-being and lead a good quality of life.
Type 2 diabetes and heart disease are interlinked. Diabetes increases heart disease risk by 2 to 4 times. Over a period of time, when the sugars are chronically high, blood vessels and nerves that support the heart get damaged. Many individuals with diabetes also have additional risk factors, such as:
These conditions can make a person vulnerable to a heart attack and stroke. Studies show that people with Type 2 diabetes are nearly twice as likely to develop heart disease compared to those without diabetes.
GLP-1 receptor agonists are medications to control high blood sugar in people with type 2 diabetes. These therapies help by:
GLP-1 therapies help control blood sugar. Beyond this, these treatment regimens provide many more benefits. Research shows that these medications can reduce the risk of major cardiovascular events such as heart attack and stroke.
In addition, GLP-1 therapies help in weight reduction. Obesity is also linked to diabetes and heart disease. Hence, GLP-1 therapies help to reduce weight and the risk of developing heart diseases.
Medications are important in controlling blood sugars. However, the medication therapies need to be combined with a healthy lifestyle, which can remain the foundation of diabetes and heart disease care.
A balanced, healthy plate can improve blood sugar, cholesterol, and blood pressure levels. Individuals with diabetes are encouraged to include:
Whole grains
Vegetables and fruits
Lean proteins
Nuts and seeds
Healthy fats
By restricting sugars, processed and ultra-processed foods, extra salt, and unhealthy trans-fats, one can reduce weight and support heart health.
Regularized physical activity routines help improve insulin sensitivity and strengthen the heart. Activities like walking, cycling, swimming, yoga, and strength training can help reduce the risk of heart disease. Experts generally recommend at least 150 minutes of moderate exercise every week.
Even small amounts of weight loss can improve blood sugar control and reduce stress on the heart. The combination of GLP-1 therapies, healthy lifestyle, controlled eating, and regular exercise gives better long-term results.
Type 2 diabetes and heart disease are closely interlinked, making complete diabetes care essential. GLP-1 therapies are changing diabetes management by offering benefits beyond glycemic control, including heart protection and weight reduction.
However, tablets and medicines alone cannot do all the work. Healthy lifestyle changes, such as balanced nutrition, regular physical activity, and proper weight management, must contribute equally. GLP-1 therapies and lifestyle changes can significantly reduce heart-related risks and improve overall well-being in individuals with Type 2 diabetes.
© 2024 Bennett, Coleman & Company Limited